Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001033
Filing Date
2019-04-15
Accepted
2019-04-15 12:37:32
Documents
30
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-022819.htm 10-Q 182004
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31.1 11039
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31.2 10968
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32.1 5352
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32.2 5321
  Complete submission text file 0001683168-19-001033.txt   826897

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20190228.xml EX-101.INS 65998
7 XBRL SCHEMA FILE cnbx-20190228.xsd EX-101.SCH 9669
8 XBRL CALCULATION FILE cnbx-20190228_cal.xml EX-101.CAL 25669
9 XBRL DEFINITION FILE cnbx-20190228_def.xml EX-101.DEF 10587
10 XBRL LABEL FILE cnbx-20190228_lab.xml EX-101.LAB 83610
11 XBRL PRESENTATION FILE cnbx-20190228_pre.xml EX-101.PRE 59552
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 19748098
SIC: 2834 Pharmaceutical Preparations